IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM

SOL #: 75N93026C00001Award Notice

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH NIAID
BETHESDA, MD, 20892, United States

Place of Performance

La Jolla, CA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Health R&D Services; Health Care Services; Applied Research (AN12)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 16, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), has issued an Award Notice for a competitive Cost Reimbursement, Level of Effort (Term) type contract for the IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM. This award covers a base period from March 15, 2026, to December 14, 2026, with a total potential performance period extending to December 14, 2030.

Scope of Work

The contract supports the Immune Epitope Database and Analysis Program, focusing on health R&D services, health care services, and applied research (PSC AN12). The work is described as dynamic, science-responsive, and result-driven, requiring flexibility due to the absence of precise specifications and difficulties in accurately estimating costs.

Contract & Timeline

  • Type: Competitive Cost Reimbursement, Level of Effort (Term)
  • Rationale for Type: A fixed-price contract was deemed not feasible due to uncertainties, lack of precise specifications, and the dynamic nature of the requirement, which would place undue risk on the Government and limit necessary flexibility.
  • Base Period: March 15, 2026 – December 14, 2026
  • Total Period of Performance (including options): March 15, 2026 – December 14, 2030
  • Set-Aside: Not specified in the award notice.
  • Place of Performance: La Jolla, CA, United States
  • Award Notice Published: March 16, 2026
  • Related Solicitation: 75N93024R00017

Additional Notes

This notice confirms the award of the contract following solicitation 75N93024R00017. The awardee is not specified in the provided information.

People

Points of Contact

Shawnice WilliamsPRIMARY
Ashley KinderdineSECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Award Notice
Posted: Mar 16, 2026
IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM | GovScope